BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+8.76%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.27B
AUM Growth
+$3.27B
(+7%)
Cap. Flow
+$8.33M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
74.79%
Holding
30
New
–
Increased
16
Reduced
6
Closed
2
Top Buys
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$22.5M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$15.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$11.3M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$7.47M |
| 5 |
Halozyme
HALO
|
$6.61M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$31.9M |
| 2 |
CELG
Celgene Corp
CELG
|
$11.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$10.4M |
| 4 |
Puma Biotechnology
PBYI
|
$9.14M |
| 5 |
PTC Therapeutics
PTCT
|
$6.72M |
Sector Composition
| 1 | Healthcare | 89.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novavax
NVAX
$1.2B
| $9.58M | 0.29% |
416,500
| – | – |
|
27
Cidara Therapeutics
CDTX
$1.61B
| $8.27M | 0.25% |
55,129
+2,938
| +6% | +$441K |
|
|
ACHN
28
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.87M | 0.18% |
1,279,340
| – | – |
|
|
29
PTC Therapeutics
PTCT
$4.41B
| – | – |
-682,912
| Closed | -$6.72M |
|
|
30
Puma Biotechnology
PBYI
$258M
| – | – |
-245,616
| Closed | -$9.14M |
|